Jun 12, 2019 - The large-cap pharma industry is doing well in 2019. Here are three stocks from the space that investors may consider betting on.
Jun 06, 2019 - Lilly's (LLY) CGRP antibody, Emgality, becomes the first and only medicine approved to treat episodic cluster headache in adults.
Jun 06, 2019 - Zacks Market Edge Highlights: Pfizer, Vanguard S&P 500 ETF, Global X Social Media ETF, Kraneshares China Internet ETF and Microsoft
Jun 06, 2019 - America's largest pharmaceutical company had plenty of good reasons not to pursue a potential new Alzheimer's treatment.
Jun 05, 2019 - Blueprint Medicines' (BPMC) excessive confidence in partners for revenue recognition is still a huge cause for concern.
Jun 05, 2019 - The stock market is volatile again. Here's how to make it through the ups and downs.
Jun 05, 2019 - The Zacks Analyst Blog Highlights: Pfizer, Coca-Cola, VMware, NIKE and AIG
Jun 05, 2019 - There's more good news with the fight against cancer than you might think.
Jun 04, 2019 - Top Research Reports for Pfizer, Coca-Cola & VMware
Jun 03, 2019 - Blueprint Medicines (BPMC) reports data on avapritinib from NAVIGATOR study for treating patients with PDGFRA Exon 18 mutant GIST and the fourth-line GIST.